Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin for Cleft Lip Repair Scarring
NCT02247193Phase 2Completed
- Sponsor
- UTHealth Houston
- Start
- Dec 2015
- Primary completion
- Jan 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in hypertrophic scar, sponsored by UTHealth Houston. Started Dec 2015; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
hypertrophic scar
Beyond the preview
Go deeper on NCT02247193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02247193.